Showing results (161-170 of 325) with videos related to
Sort By:
Pageof 33
Seminars in Thrombosis and Hemostasis|January 1, 1995
Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudinD D Callas, D Hoppensteadt, J FareedTherapeutic Drug Monitoring|January 1, 1988
Pharmacokinetics of heparins differing in mean molecular weight using a Xa amidolytic and Heptest clotting methodR M Emanuele, A Racanelli, J FareedArchives of Neurology|September 1, 1980
Lithium carbonate therapy for cluster headache. Changes in number of platelets, and serotonin and histamine levelsJ L Medina, J Fareed, S DiamondSeminars in Thrombosis and Hemostasis|October 1, 1991
Influence of hypersulfated lactobionic acid amides on tissue plasminogen activator releaseH P Klöcking, A Hoffmann, J FareedExpert Opinion on Investigational Drugs|January 5, 2002
Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disordersB Kaiser, D A Hoppensteadt, J FareedExpert Opinion on Investigational Drugs|July 5, 2005
Recombinant TFPI and variants: potential implications in the treatment of cardiovascular disordersB Kaiser, D H Hoppensteadt, J FareedAngiology|February 10, 1998
The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case reportB E Lewis, Y Rangel, J FareedDie Pharmazie|November 1, 2001
Antithrombin and anti-Xa agents in the control of thrombogenesisJ Fareed, T Shaikh, D A HoppensteadtSeminars in Thrombosis and Hemostasis|January 1, 1995
Studies on the thrombogenic effects of recombinant tissue factor. In vivo versus ex vivo findingsD D Callas, P Bacher, J FareedThrombosis Research|October 29, 1998
Modulation of vasoconstriction by clopidogrel and ticlopidineL H Yang, D Hoppensteadt, J FareedPageof 33